The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—hosts an oncology policy summit focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment.
David Wetter, PhD, has been honored for pioneering cancer health equity strategies, transforming research into practical solutions, and fostering vital community partnerships for underserved populations and rural communities.
Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer Centers (NCI-DCCs).
A cancer diagnosis scares most people. Those outside of large population centers like Albuquerque have the additional concern of having to travel to get timely, specialized medical treatment. Now, a new program at The University of New Mexico Comprehensive Cancer Center aims to streamline the process for all New Mexicans, regardless of where they live in the state.
A new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas.
Laurence Belfer, on behalf of Robert Belfer and the Belfer family, today announced a $20 million gift to The University of Texas MD Anderson Cancer Center to strengthen neurodegeneration research through the Belfer Neurodegeneration Consortium (BNDC), a transformative multi-institutional initiative to advance the study and treatment of Alzheimer’s disease.
20221027104337.jpg&width=400&height=400)
A study led by Yale scientists, published April 25 in the journal Science Immunology, investigated the potential causes associated with T cell exclusion using a genome-wide screen of more than 1,000 human proteins.
20240208171546.png&width=400&height=400)
Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection. With critical support from longtime MSK Board Member Bruce Ratner, the Ratner Early Detection Initiative (REDI) draws from MSK’s deep experience in cancer science and discovery, community engagement, and compassionate patient care.
Researchers from University of California San Diego have developed a new AI tool to that generate new drug candidates for cancer, which could help streamline the typically laborious drug discovery process.
Researchers at Bar-Ilan University have unveiled a technology that promises to improve cancer treatment decisions based on a patient's biopsy.
Follow-on analysis of results from the phase 3 PSMAfore study, along with the overall study results, support the consideration of 177Lu-PSMA-617 as a new standard treatment approach for this prevalent population of patients with mCRPC. Research led by Dana-Farber Cancer Institute and others.
The Wistar Institute assistant professor Dr. Filippo Veglia has discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so that the tumor can grow unimpeded by the body’s defenses.
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.
Receiving a cancer diagnosis can be one of the most stressful, pivotal moments in an individual’s life. With May being Mental Health Awareness Month, Fred Hutch social psychologist and researcher Megan J. Shen, PhD, shares tips for coping with a cancer diagnosis and how patients and their caregivers can navigate appointments with their oncologists.
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two clinical trial conducted by UT Southwestern Medical Center.
Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times, a hallmark of cancer cells.
Many pancreatic tumors are like malignant fortresses, surrounded by a dense matrix of collagen and other tissue that shields them from immune cells and immunotherapies that have been effective in treating other cancers. Employing bacteria to infiltrate that cancerous fortification and deliver these drugs could aid treatment for pancreatic cancer, according to newly published findings from a team of University of Wisconsin–Madison researchers.
A new perspective paper explores the current state and future directions of precision medicine in colorectal cancer (CRC). It outlines advancements in molecular testing and their implications for targeted and immunological therapies in CRC.
Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming. This discovery potentially opens up new avenues for cancer treatments that target cellular metabolism.
Four proposed state-of-the art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care. Some had less than 50% accuracy, which is not suitable for clinical practice.
The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, is teaming up with the AIM at Melanoma Foundation for the 14th year to host a free melanoma symposium for patients, caregivers and clinicians.
Physician-scientists from the Department of Urology at Cedars-Sinai will be attending the American Urological Association (AUA) Annual Meeting May 3-6 in San Antonio, Texas, and are available to discuss the latest research and innovations in urological care.
Patients in South Florida with metastatic melanoma will soon have access to tumor-infiltrating lymphocyte therapy, or TIL. The therapy will be available at Sylvester Comprehensive Cancer Center and will be South Florida’s only center offering this treatment.
Sharon Dent, Ph.D., professor of Epigenetics and Molecular Carcinogenesis at The University of Texas MD Anderson Cancer Center, has been elected to the National Academy of Sciences (NAS). Dent is a global leader in the field of chromatin research whose foundational work has helped define the role of chromatin in cancer growth and development.
Connecticut Magazine released its “Top Doctors” issue today, listing some of the state’s best physicians, who provide exceptional care for patients. This year’s list includes 109 Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians, a 35% increase in “Top Doctors” for SCH and YCC from last year.
A research team from Tufts University School of Medicine and Massachusetts General Hospital is now reporting evidence that hillocks and their stem cells are physiologically distinct from other cells within the lung and consist of a stratified outer layer of scale-like squamous cells that protect an underlying layer of rapidly expanding basal stem cells that are capable of restoring airway tissue after injury.
Results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor efficacy in patients with liver cancer who failed their original front-line treatment. The foundational biomedical research leading to this important study and important outcome originated from research in the Vaccine & Immunotherapy Center at The Wistar Institute.
International collaboration to improve cancer outcomes in Sub-Saharan Africa is working to update consensus harmonized guidelines on several key subjects in oncology, including how best to treat people with both cancer and HIV.
The University of Texas MD Anderson Cancer Center and the Pan American Health Organization (PAHO) today announced the signing of an agreement to strengthen cancer prevention and control initiatives across the Americas. The event took place in Washington, D.C., with leaders from both organizations.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for April 2024.
A team led by a Houston Methodist physician established a hypothesis that the microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy receptors found on each section of the pancreas, differ. This could impact the way cancer of the pancreas is treated.
Hackensack Meridian Mountainside Medical Center is proud to announce the successful completion of its first bronchoscopy procedure using the Ion Endoluminal System, a cutting-edge robotic-assisted technology designed for minimally invasive lung biopsies.
Ann & Robert H. Lurie Children’s Hospital of Chicago is pleased to announce the first pediatric use of the novel fluorescent agent CYTALUX during surgery to remove lung metastases. The drug allows surgeons to better visualize cancer in the lung, as well as potentially detect additional cancerous nodules missed by preoperative imaging.
Drs. Kachikis and Eckert stressed that more research and funding are needed, specifically in treatments that might help women remain pregnant while fighting cancers and other diseases.
In a significant stride towards personalized cancer care, the National Cancer Center Japan (NCCJ) has marked a decade of progress in cancer genomic medicine (CGM). A comprehensive review outlines the evolution of CGM in Japan, highlighting the pivotal role of the NCCJ in this advancement. The study encapsulates the historical milestones, current achievements, and future directions in the field of CGM.
A recent study in gastrointestinal (GI) cancer research reveals a promising advancement in predicting patient responses to immune checkpoint inhibitor (ICI) therapy. The newly developed DNA damage response-related immune activation (DRIA) signature could serve as a groundbreaking biomarker, providing valuable guidance for ICI therapy decisions.
Susan G. Komen believes final recommendations made by the U.S. Preventive Services Task Force (USPSTF) on screening mammography diminish the significance of regular screening mammography and could exacerbate the troubling fact that 25% of eligible women have foregone mammograms in the past two years.
Challenges remain in ensuring equitable access to screening and addressing gaps in evidence regarding supplemental screening modalities and the adoption of artificial intelligence (AI) technologies, notes Joann Elmore, MD, MPH, a professor of medicine at the David Geffen School of Medicine at UCLA in a newly published editorial in JAMA.
A groundbreaking study has recognized the cGAS-STING signaling pathway as a formidable ally in the immune system's battle against cancer. This pivotal discovery may pave the way for innovative immunotherapies capable of amplifying the body's inherent defenses to detect and eradicate cancer cells, signifying a substantial advance towards more potent cancer treatments.
The final United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations, while an improvement over previous guidance, do not go far enough to save more women’s lives. Women at average risk for breast cancer should start annual screening at age 40.
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose disease has progressed following initial frontline standard of care immunotherapy that includes an immune checkpoint inhibitor alone or combined with chemotherapy.
While skin cancer is one of the most preventable types of cancer, a recent survey of more than 1,000 U.S. adults found that an increasing number of Americans are reporting sunburn despite knowing how to protect themselves from the sun’s harmful rays.
Cedars-Sinai Guerin Children’s pediatric oncologist Leo Mascarenhas, MD, MS, has been reelected as Children’s Oncology Group (COG) voting body chair for a second five-year term.
The Vineyard Cares Business of the Year Award celebrates Huntsman Cancer Institute’s plan to establish a comprehensive cancer center in Vineyard, which will bring crucial cancer research and care closer to more communities in the region.
Naples (FL) firefighter, David Perez, initially kept his cancer diagnosis quiet, but now speaks out about the importance of fire fighter health and cancer in the fire service. “My eyes really opened up as to how many firefighters have been diagnosed with cancer and how many people there [Sylvester’s Firefighter Cancer Initiative] are fighting for us,” Perez said.
A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the US, relative to overall screening rates in the country.
A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the U.S., relative to overall screening rates in the country.
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
